Massive Transfusion in Pediatric Patients
- PMID: 33494884
- DOI: 10.1016/j.cll.2020.10.003
Massive Transfusion in Pediatric Patients
Abstract
Massive transfusion in pediatric patients is infrequent but associated with much higher mortality than in adults. Blood transfusion and hematology has conceptualized ideas such as blood failure and the interplay of the blood-endothelium interface to understand coagulopathy in the context of hemorrhagic shock. Researchers are still searching for an appropriate definition of what constitutes a pediatric massive transfusion. There is no universally accepted protocol for massive transfusion and how to address the many complications that can arise. Pharmacologic adjuncts to resuscitation may prove beneficial in reducing coagulopathy during pediatric massive transfusion, but high-quality evidence has not yet emerged.
Keywords: Blood failure; Endotheliopathy; Hemorrhage; Pediatric massive transfusion; Whole blood.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure P.C. Spinella: consultant for Secure Transfusion Services, Cerus, and Octapharma. J.W. Cannon: DOD funding on resuscitation/decision support, UpToDate royalties on REBOA (resuscitative endovascular balloon occlusion of the aorta). The other authors have nothing to disclose.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
